Coronavirus vaccine trial begins in AIIMS

The AIIMS-Delhi has begun clinical trials for Covaxin- an indigenously developed Covid-19 vaccine candidate- from today. This is Phase-1 of human clinical trials of Bharat Biotech's Covaxin. AIIMS-Delhi is among the 12 hospitals selected by the apex medical body Indian Council of Medical Research for conducting Phase 1 and 2 human trials of Covaxin. Watch the video to know more.